These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 30939845)
1. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling. Takayama KI Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30939845 [TBL] [Abstract][Full Text] [Related]
2. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression. Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF. Takayama KI; Suzuki T; Fujimura T; Yamada Y; Takahashi S; Homma Y; Suzuki Y; Inoue S Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10461-10466. PubMed ID: 28893982 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells. Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018 [TBL] [Abstract][Full Text] [Related]
5. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells. Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835 [TBL] [Abstract][Full Text] [Related]
6. PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells. Liu W; Wang C; Wang S; Zeng K; Wei S; Sun N; Sun G; Wang M; Zou R; Liu W; Lin L; Song H; Jin Z; Zhao Y Int J Biol Sci; 2021; 17(1):188-203. PubMed ID: 33390843 [TBL] [Abstract][Full Text] [Related]
7. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells. Melnyk JE; Steri V; Nguyen HG; Hann B; Feng FY; Shokat KM Bioorg Med Chem; 2020 Oct; 28(20):115712. PubMed ID: 33069070 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the androgen receptor splicing in prostate cancer cells. Liu LL; Xie N; Sun S; Plymate S; Mostaghel E; Dong X Oncogene; 2014 Jun; 33(24):3140-50. PubMed ID: 23851510 [TBL] [Abstract][Full Text] [Related]
9. Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells. Ferraldeschi R; Welti J; Powers MV; Yuan W; Smyth T; Seed G; Riisnaes R; Hedayat S; Wang H; Crespo M; Nava Rodrigues D; Figueiredo I; Miranda S; Carreira S; Lyons JF; Sharp S; Plymate SR; Attard G; Wallis N; Workman P; de Bono JS Cancer Res; 2016 May; 76(9):2731-42. PubMed ID: 27197266 [TBL] [Abstract][Full Text] [Related]
10. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model. Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672 [TBL] [Abstract][Full Text] [Related]
11. The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation. Nakata D; Nakao S; Nakayama K; Araki S; Nakayama Y; Aparicio S; Hara T; Nakanishi A Biochem Biophys Res Commun; 2017 Jan; 483(1):271-276. PubMed ID: 28025139 [TBL] [Abstract][Full Text] [Related]
12. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. Takayama KI; Fujimura T; Suzuki Y; Inoue S Commun Biol; 2020 Jul; 3(1):393. PubMed ID: 32704143 [TBL] [Abstract][Full Text] [Related]
13. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
14. [The mechanisms of prostate cancer progression through androgen receptor]. Goto Y; Sakamoto S; Ichikawa T Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis. Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843 [TBL] [Abstract][Full Text] [Related]
16. Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer. Seltzer S; Giannopoulos PN; Bismar TA; Trifiro M; Paliouras M Asian J Androl; 2023; 25(3):296-308. PubMed ID: 36259569 [TBL] [Abstract][Full Text] [Related]
17. A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities. Hu R; Isaacs WB; Luo J Prostate; 2011 Nov; 71(15):1656-67. PubMed ID: 21446008 [TBL] [Abstract][Full Text] [Related]
18. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells. Liu L; Dong X PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799 [TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cells. Nakata D; Koyama R; Nakayama K; Kitazawa S; Watanabe T; Hara T Prostate; 2017 Jun; 77(9):955-961. PubMed ID: 28397338 [TBL] [Abstract][Full Text] [Related]
20. Androgen receptor nuclear localization correlates with AR-V7 mRNA expression in circulating tumor cells (CTCs) from metastatic castration resistance prostate cancer patients. Worroll D; Galletti G; Gjyrezi A; Nanus DM; Tagawa ST; Giannakakou P Phys Biol; 2019 Mar; 16(3):036003. PubMed ID: 30763921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]